(Q40373403)

19 September 2017

Fusion of the HSV-1 tegument protein vp22 to cytosine deaminase confers enhanced bystander effect and increased therapeutic benefit (English)

1 reference

Herpes simplex virus type 1

19 September 2017

1 reference

K C Lee

1

1 reference

19 September 2017

D A Hamstra

2

1 reference

19 September 2017

S Bullarayasamudram

3

1 reference

19 September 2017

M S Bhojani

4

1 reference

19 September 2017

B A Moffat

5

1 reference

19 September 2017

K J Dornfeld

6

1 reference

19 September 2017

B D Ross

7

1 reference

19 September 2017

A Rehemtulla

8

1 reference

19 September 2017

language of work or name

1 reference

1 January 2006

1 reference

19 September 2017

1 reference

19 September 2017

13

1 reference

19 September 2017

127-137

1 reference

19 September 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302631

19 September 2017

0 references

cites work

Gene directed enzyme prodrug therapy for cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302631

Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302631

Enzyme/prodrug therapy for head and neck cancer using a catalytically superior cytosine deaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302631

The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302631

Combined radiation and gene therapy for brain tumors with adenovirus-mediated transfer of cytosine deaminase and uracil phosphoribosyltransferase genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302631

Gene therapy for prostate cancer using the cytosine deaminase/uracil phosphoribosyltransferase suicide system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302631

Gene therapy -- promises, problems and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302631

Gene therapy: trials and tribulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302631

Cancer gene therapy: fringe or cutting edge?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302631

Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302631

Can VP22 resurrect gene therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302631

A brief introduction to cell-penetrating peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302631

Cell penetrating peptides in drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302631

Chances and pitfalls of cell penetrating peptides for cellular drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302631

Intercellular trafficking and protein delivery by a herpesvirus structural protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302631

Herpes simplex virus tegument protein VP22 contains overlapping domains for cytoplasmic localization, microtubule interaction, and chromatin binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302631

Intercellular trafficking of adenovirus-delivered HSV VP22 from the retinal pigment epithelium to the photoreceptors--implications for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302631

Intercellular trafficking of VP22-GFP fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302631

Intercellular delivery of functional p53 by the herpesvirus protein VP22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302631

Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302631

VP22 enhanced intercellular trafficking of HSV thymidine kinase reduced the level of ganciclovir needed to cause suicide cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302631

Enhanced suicide gene effect by adenoviral transduction of a VP22-cytosine deaminase (CD) fusion gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302631

Bovine herpesvirus tegument protein VP22 enhances thymidine kinase/ganciclovir suicide gene therapy for neuroblastomas compared to herpes simplex virus VP22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302631

Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302631

5-fluorouracil metabolism monitored in vivo by 19F NMR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302631

Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302631

Prodrug activation enzymes in cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302631

Gene directed enzyme/prodrug therapy of cancer: historical appraisal and future prospectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302631

Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302631

Molecular imaging of gene expression and efficacy following adenoviral-mediated brain tumor gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302631

Concomitant expression of E. coli cytosine deaminase and uracil phosphoribosyltransferase improves the cytotoxicity of 5-fluorocytosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302631

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.GT.3302631

1 reference

Dimensions Publication ID

19 September 2017

0 references

1 reference